Isocitrate dehydrogenase (IDH) as target for anticancer therapy in brain and gastrointestinal cancers
Discover Medicine · 10.08.2026 · 3 (1)
DOI: 10.1007/s44337-026-00669-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Discover Medicine, online erschienen am 10.08.2026. Verfasst von Virginia Agnetti und 10 weiteren Autor:innen. Die Arbeit nennt 194 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Agnetti, V., Acunzo, A., Airò, G., Lazzarin, A., Lai, E., Michiara, M., Martella, S., Demurtas, L., Scartozzi, M., Solinas, C., & Tommasi, C. (2026). Isocitrate dehydrogenase (IDH) as target for anticancer therapy in brain and gastrointestinal cancers. Discover Medicine, 3(1). https://doi.org/10.1007/s44337-026-00669-7
Vancouver
Agnetti V, Acunzo A, Airò G, Lazzarin A, Lai E, Michiara M, et al. Isocitrate dehydrogenase (IDH) as target for anticancer therapy in brain and gastrointestinal cancers. Discover Medicine. 2026;3(1). doi:10.1007/s44337-026-00669-7
BibTeX
@article{Agnetti2026,
author = {Agnetti, Virginia and Acunzo, Alessandro and Airò, Giulia and Lazzarin, Alessandro and Lai, Eleonora and Michiara, Maria and Martella, Serafina and Demurtas, Laura and Scartozzi, Mario and Solinas, Cinzia and Tommasi, Chiara},
title = {Isocitrate dehydrogenase (IDH) as target for anticancer therapy in brain and gastrointestinal cancers},
journal = {Discover Medicine},
year = {2026},
volume = {3},
number = {1},
doi = {10.1007/s44337-026-00669-7}
}
EUVIMED